Novartis Ag Income Statement (2009-2026) | NVSEF

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	12.96B	0.23B	25.37B	0.26B	12.78B	0.24B	0.25B	0.32B	11.44B		22.23B		12.51B		24.34B		14.05B
Cost of Revenue (Quarter)	3.91B	0.24B	0.24B	0.29B	3.75B	0.24B	0.25B	0.33B	3.34B		6.33B		3.17B		6.27B		3.32B
Gross Profit (Quarter)	0.00B	0.02B	0.01B	0.03B	9.33B	1,000.00B	-1000.00B	5,000.00B	8.40B		16.46B		9.70B		18.72B		11.51B
Operating items
Research & Development (Quarter)	-2.40B	-0.22B	-0.24B	-0.21B	-2.50B	-0.19B	-0.23B	-0.22B	-2.30B		-4.88B		-2.37B		-4.79B		-2.73B
Selling, General & Administrative (Quarter)	-3.75B	-0.48B	-0.57B	-0.51B	-3.58B	-0.48B	-0.56B	-0.54B	-3.09B		-5.98B		-3.09B		-5.93B		-3.44B
Restructuring Costs (Quarter)
Operating Expenses (Quarter)	-6.15B	-0.70B	-0.81B	-0.72B	-6.08B	-0.67B	-0.79B	-0.76B	-5.39B		-10.86B		-5.46B		-10.72B		-6.17B
Operating Income (Quarter)	3.48B	0.44B	0.39B	0.39B	2.23B	0.38B	0.27B	0.32B	2.81B		5.42B		4.01B		7.39B		4.86B
EBIT (Quarter)	3.48B	0.44B	0.39B	0.39B	2.23B	0.38B	0.27B	0.32B	2.81B		5.42B		4.01B		7.39B		4.86B
Non-operating items
Non Operating Investment Income (Quarter)
Other Non Operating Income (Quarter)	-0.01B	-0.02B	-0.03B	0.02B	0.02B	-0.03B	0.02B	0.10B	0.09B	0.01B	0.02B	0.01B	0.07B	0.03B	0.03B	0.02B	-0.04B	-0.02B	-0.09B	-0.05B
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	3.51B	0.64B	5.96B	0.59B	2.04B	0.58B	4.71B	0.52B	2.67B		5.19B		3.84B		6.97B		4.53B
Profit After Tax (Quarter)	2.90B	0.64B	4.95B	0.59B	1.70B	0.58B	3.91B	0.52B	2.32B		4.61B		3.25B		5.93B		4.02B
Equity Income (Quarter)	0.24B	0.22B	0.00B	-0.00B		-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.03B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Income from Non-Controlling Interests (Quarter)	-0.00B		-0.00B	0.16B	0.08B	0.08B	-0.00B	0.08B	0.08B	0.00B				0.12B	0.00B	0.00B	-0.02B	0.42B	-0.01B	0.41B
Income from Continuing Operations (Quarter)	3.51B	0.64B	5.96B	0.59B	2.04B	0.58B	4.71B	0.52B	2.67B		5.19B		3.84B		6.97B		4.53B
Consolidated Net Income (Quarter)	3.51B	0.64B	5.96B	0.59B	2.04B	0.24B	0.15B	0.14B	0.05B	0.25B	0.19B		3.84B		6.97B		4.53B
Income towards Parent Company (Quarter)	3.51B	0.64B	5.96B	0.59B	2.04B	0.24B	0.15B	0.14B	0.05B	0.25B	0.19B		3.84B		6.97B		4.53B
Net Income towards Common Stockholders (Quarter)	3.51B	0.64B	5.96B	0.59B	2.04B	0.24B	0.15B	0.14B	0.05B	0.25B	0.19B		3.84B		6.97B		4.53B
Additional items
EPS (Basic) (Quarter)	3.84	0.71	6.61	0.66	2.29	0.28	0.07	0.17	0.05	0.30	0.09		4.84		8.79		2.31
EPS (Weighted Average and Diluted) (Quarter)	1.55	0.19B	0.56B	0.60B	0.92	0.11B	0.05B	0.14B	0.04B	0.09B	0.05B		1.33B		1.19B		1.17B
Shares Outstanding (Weighted Average) (Quarter)	0.91B	0.90B	0.90B	0.90B	0.89B	0.89B	2.12B	0.84B	0.84B	0.82B	2.08B	0.79B	0.79B	4.50	0.79B	1.83	1.96B	0.77B	0.77B	0.74B
Shares Outstanding (Diluted Average) (Quarter)	2.26B	3.41	10.63	0.99	2.21B	2.14	2.75	1.01	1.09	2.83	4.10	1.31	2.89	4.46	5.87	1.82	3.88	5.90	7.15	1.65
EBITDA (Quarter)	3.48B	0.44B	0.39B	0.39B	2.23B	0.38B	0.27B	0.32B	2.81B		5.42B		4.01B		7.39B		4.86B
Interest Expenses (Quarter)	-0.20B	-0.20B	-0.21B	-0.20B	-0.20B	-0.21B	-0.21B	-0.20B	-0.22B	-0.22B	-0.22B	-0.22B	-0.25B	-0.26B	-0.28B	-0.27B	-0.29B	-0.28B	-0.30B	-0.34B

Research Tools

Developers

Novartis Ag Income Statement (2009-2026) | NVSEF

Research Tools

Developers

Novartis Ag Income Statement (2009-2026) | NVSEF

Create an account

Sign In

Reset Password